TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis

被引：0

作者：

Whalen, William ^{[1
]}

Berger, Kristin ^{[1
]}

Kim, John S. ^{[4
]}

Simmons, Will ^{[2
]}

Ma, Shwu-Fan ^{[4
]}

Kaner, Robert J. ^{[1
,3
]}

Martinez, Fernando J. ^{[1
]}

Anstrom, Kevin J. ^{[5
]}

Parfrey, Helen ^{[6
,7
]}

Maher, Toby M. ^{[8
,9
,10
]}

Hammond, Matthew ^{[11
,12
]}

Clark, Allan B. ^{[11
,12
]}

Thickett, David ^{[13
]}

Jenkins, R. Gisli ^{[9
,10
]}

Wilson, Andrew M. ^{[12
]}

Noth, Imre ^{[4
]}

机构：

[1] New York Presbyterian Weill Cornell Med, Div Pulm & Crit Care, Dept Med, New York, NY 10032 USA

[2] New York Presbyterian Weill Cornell Med, Dept Populat Hlth Sci, Div Biostat, New York, NY USA

[3] New York Presbyterian Weill Cornell Med, Dept Genet Med, New York, NY USA

[4] Univ Virginia, Dept Med, Sch Med, Charlottesville, VA USA

[5] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA

[6] Univ Cambridge, Cambridge, England

[7] Royal Papworth Hosp Natl Hlth Serv Fdn Trust, Cambridge, England

[8] Univ Southern Calif, Los Angeles, CA USA

[9] Imperial Coll London, Natl Heart & Lung Inst, Imperial Biomed Res Ctr, London, England

[10] Imperial Coll London, Natl Inst Hlth & Care Res, Margaret Turner Warwick Ctr Fibrosing Lung Dis, London, England

[11] Univ East Anglia, Norwich Clin Trials Unit, Norwich, England

[12] Univ East Anglia, Norwich Med Sch, Norwich, England

[13] Univ Birmingham, Inst Inflammat & Aging, Birmingham, England

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 210卷 / 04期

关键词：

DOXYCYCLINE; SUSCEPTIBILITY; THERAPY; DEATH;

D O I：

10.1164/rccm.202312-2224LE

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：508 / 511

页数：4

共 50 条

[41] Advances in the treatment of idiopathic pulmonary fibrosis
Sergew, Amen
Brown, Kevin K.
[J]. EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (04) : 537 - 553
[42] TREATMENT OF DIFFUSE IDIOPATHIC PULMONARY FIBROSIS
SCHLEHE, H
KONIETZKO, N
ALTENSTETTER, F
MATTHYS, H
[J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1973, 103 (44) : 1543 - 1547
[43] Pharmacological treatment of idiopathic pulmonary fibrosis (update) and progressive pulmonary fibrosis
Behr, Juergen
Bonella, Francesco
Frye, Bjoern C.
Guenther, Andreas
Hagmeyer, Lars
Henes, Joerg
Klemm, Philipp
Koschel, Dirk
Kreuter, Michael
Leuschner, Gabriela
Nowak, Dennis
Prasse, Antje
Quadder, Bernd
Sitter, Helmut
Costabel, Ulrich
[J]. PNEUMOLOGIE, 2023, 77 (02): : 94 - 119
[44] Assessing the treatment effect from multiple trials in idiopathic pulmonary fibrosis
Richeldi, Luca
[J]. EUROPEAN RESPIRATORY REVIEW, 2012, 21 (124): : 147 - 151
[45] Targeted Sequencing Identified Novel Common Genetic Variants Of Tollip Associated With Idiopathic Pulmonary Fibrosis Susceptibility
Ma, S. -F.
Acosta-Herrera, M.
Huang, Y.
Barreto-Luis, A.
Vij, R.
Oldham, J.
Hysi, P.
Flores, C.
Noth, I.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
[46] Nintedanib (OFEV) in the treatment of idiopathic pulmonary fibrosis
Fukihara, Jun
Kondoh, Yasuhiro
[J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (12) : 1247 - 1254
[47] Novel Mechanisms and Treatment of Idiopathic Pulmonary Fibrosis
Elmufdi, Firas
Henke, Craig A.
Perlman, David M.
Tomic, Rade
Kim, Hyun Joo
[J]. DISCOVERY MEDICINE, 2015, 20 (109) : 145 - 153
[48] Idiopathic pulmonary fibrosis: current diagnosis and treatment
Amaral, Alexandre Franco
Braga Colares, Philippe De Figueiredo
Kairalla, Ronaldo Adib
[J]. JORNAL BRASILEIRO DE PNEUMOLOGIA, 2023, 49 (04)
[49] Idiopathic pulmonary fibrosis - Part 2: Treatment
Lode, H
Erbes, R
Raffenberg, M
[J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (14) : 399 - 401
[50] Etiology and treatment of cough in idiopathic pulmonary fibrosis
Vigeland, Christine L.
Hughes, Andrew H.
Horton, Maureen R.
[J]. RESPIRATORY MEDICINE, 2017, 123 : 98 - 104

← 1 2 3 4 5 →